A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

NCT07199452 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MK-4646
DRUG: Rifabutin

Sponsor

Merck Sharp & Dohme LLC